BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25118504)

  • 1. [Effects of metformin on the survival of the SKOV-3 ovarian cancer cell line and the expression of genes encoding enzymes involved in O-Glcnacylation].
    Rogalska A; Wójcik-Krowiranda K; Forma E; Ciesielski P; Bieńkiewicz A; Brys M; Krzeslak A; Marczak A
    Ginekol Pol; 2014 Jul; 85(7):521-6. PubMed ID: 25118504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
    Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
    Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3).
    Rogalska A; Forma E; Bryś M; Śliwińska A; Marczak A
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30217067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
    Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
    Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast cells as an assay system for in vivo O-GlcNAc modification.
    Nakanishi H; Li F; Han B; Arai S; Gao XD
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
    Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
    Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
    Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
    Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of O-GlcNAcylation is important for pig preimplantation development.
    Shibutani M; Mori T; Miyano T; Miyake M
    J Reprod Dev; 2015; 61(4):341-50. PubMed ID: 26004176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.
    Nagel AK; Ball LE
    Amino Acids; 2014 Oct; 46(10):2305-16. PubMed ID: 25173736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OGT: a short overview of an enzyme standing out from usual glycosyltransferases.
    Aquino-Gil M; Pierce A; Perez-Cervera Y; Zenteno E; Lefebvre T
    Biochem Soc Trans; 2017 Apr; 45(2):365-370. PubMed ID: 28408476
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer.
    Starska K; Forma E; Brzezińska-Błaszczyk E; Lewy-Trenda I; Bryś M; Jóźwiak P; Krześlak A
    Clin Exp Med; 2015 Nov; 15(4):455-68. PubMed ID: 25315705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations.
    Krześlak A; Wójcik-Krowiranda K; Forma E; Bieńkiewicz A; Bryś M
    Ginekol Pol; 2012 Jan; 83(1):22-6. PubMed ID: 22384635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Global
    Sherazi AA; Jariwala KA; Cybulski AN; Lewis JW; Karagiannis J; Cumming RC; Timoshenko AV
    Anticancer Res; 2018 Dec; 38(12):6691-6697. PubMed ID: 30504378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altering O-linked β-N-acetylglucosamine cycling disrupts mitochondrial function.
    Tan EP; Villar MT; E L; Lu J; Selfridge JE; Artigues A; Swerdlow RH; Slawson C
    J Biol Chem; 2014 May; 289(21):14719-30. PubMed ID: 24713701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc is required for the survival of primed pluripotent stem cells and their reversion to the naïve state.
    Miura T; Nishihara S
    Biochem Biophys Res Commun; 2016 Nov; 480(4):655-661. PubMed ID: 27983978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-deGlcNAcylation is required for Entamoeba histolytica-induced HepG2 cell death.
    Lee YA; Min A; Shin MH
    Microb Pathog; 2018 Oct; 123():285-295. PubMed ID: 30016682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer.
    Zhou F; Yang X; Zhao H; Liu Y; Feng Y; An R; Lv X; Li J; Chen B
    Theranostics; 2018; 8(19):5200-5212. PubMed ID: 30555541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.